Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Licensed medicineStub

Sermorelin

GHRH analogue (GRF 1-29)

The first 29 amino acids of growth hormone releasing hormone. It was licensed in the United States for growth hormone deficiency in children and later withdrawn from sale for commercial reasons.

Reconstitution calculator

At a glance

Licensed medicine

A regulator has licensed it for at least one use, in at least one country. That says nothing about uses outside the license.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine: Sermorelin

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

25
papers on PubMed
18
of them in people
0
randomized trials
7
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on Sermorelin itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Sermorelin; no amount here is a recommendation.

Sermorelin: on PubMed

What PubMed held for Sermorelin on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

25
papers
18
in humans
0
clinical trials
0
randomized trials
2012: 0 papers122013: 0 papers2014: 0 papers142015: 2 papers2016: 2 papers162017: 1 papers2018: 0 papers182019: 0 papers2020: 2 papers202021: 2 papers2022: 2 papers222023: 3 papers2024: 1 papers242025: 1 papers2026: 7 papers so far26
Papers per year, 2012 to 2026. The most in one year: 7.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Advances in the detection of growth hormone releasing hormone synthetic analogs

    StudyMemdouh S, Gavrilović I, Ng K, et al. Drug testing and analysis, 2021. PMID 34665524

  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    ReviewRahman OF, Lee SJ, Seeds WA Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200

  3. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

    ReviewMendias CL, Awan TM Sports medicine (Auckland, N.Z.), 2026. PMID 41966639

  4. In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides

    StudyGonzález-López NM, Guerra-Acero-Turizo LM, Blanco-Medina I, et al. Biomedical chromatography : BMC, 2023. PMID 37688464

  5. Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples

    StudyCristea CD, Radu M, Toboc A, et al. Analytical biochemistry, 2023. PMID 37806509

  6. Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis

    StudyOtin J, Tran NT, Benoit A, et al. Electrophoresis, 2023. PMID 36787346

Search used: ("Sermorelin"[tiab]). Run it on PubMed

Research links

Also in GH axis